FindTrial
Sign In

Study to assess the prognostic aspects of chronic kidney disease through ancient oil drop test with special reference to various laboratory investigations

An observational study to assess the prognostic aspects of chronic kidney disease through Tailabindu Pariksha with special reference to changes in glomerular filtration rate (GFR) and albuminuria categorizations - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071313
Enrollment
250
Registered
2024-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N08- Glomerular disorders in diseases classified elsewhere

Interventions

None listed

Sponsors

Sagarika Purohit
Lead Sponsor
Dr Dolly Thakur
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients who willingly participate and has given written consent. Diagnosed Subjects of CKD irrespective of any age and genders. Patient who are able to give urine sample more than 50ml

Exclusion criteria

Exclusion criteria: Unconscious patient Menstruating women Patient under catheterization

Design outcomes

Primary

MeasureTime frame
The Prognosis of Chronic Kidney Disease Through Tailabindu Pariksha WSR to Changes in Glomerular Filtration Rate (GFR) And Albuminuria Categorizations will be assessed.Timepoint: 6 months—

Secondary

MeasureTime frame
To study the Doshic predominance in subjects of CKD through Tailabindu Pariksha To see any specific pattern found in the urine of CKD patient after the Tailabindu Pariksha To assess the Dasavidha rogi pariksha of CKD patientTimepoint: 4 months—

Countries

India

Contacts

Public ContactSagarika Purohit

Shri Dhanwantry Ayurvedic College and Hospital,Sector 46 b Chandigarh

sagarikapurohit12@gmail.com8917621062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026